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Abstract
Introduction
Health financing reforms in low- and middle- income countries (LMICs) over the past
decades have focused on achieving equity in financing of health care delivery through uni-
versal health coverage. Benefit and financing incidence analyses are two analytical meth-
ods for comprehensively evaluating how well health systems perform on these objectives.
This systematic review assesses progress towards equity in health care financing in LMICs
through the use of BIA and FIA.
Methods and Findings
Key electronic databases including Medline, Embase, Scopus, Global Health, CinAHL,
EconLit and Business Source Premier were searched. We also searched the grey literature,
specifically websites of leading organizations supporting health care in LMICs. Only studies
using benefit incidence analysis (BIA) and/or financing incidence analysis (FIA) as explicit
methodology were included. A total of 512 records were obtained from the various sources.
The full texts of 87 references were assessed against the selection criteria and 24 were
judged appropriate for inclusion. Twelve of the 24 studies originated from sub-Saharan
Africa, nine from the Asia-Pacific region, two from Latin America and one from the Middle
East. The evidence points to a pro-rich distribution of total health care benefits and progres-
sive financing in both sub-Saharan Africa and Asia-Pacific. In the majority of cases, the dis-
tribution of benefits at the primary health care level favoured the poor while hospital level
services benefit the better-off. A few Asian countries, namely Thailand, Malaysia and Sri
Lanka, maintained a pro-poor distribution of health care benefits and progressive financing.
Conclusion
Studies evaluated in this systematic review indicate that health care financing in LMICs ben-
efits the rich more than the poor but the burden of financing also falls more on the rich.
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There is some evidence that primary health care is pro-poor suggesting a greater invest-
ment in such services and removal of barriers to care can enhance equity. The results over-
all suggest that there are impediments to making health care more accessible to the poor
and this must be addressed if universal health coverage is to be a reality.
Introduction
Concerns about the poor not getting adequate access to quality health care are widespread in
low- and middle-income countries (LMICs). Governments, development agencies and civil
society organisations have highlighted the enormous gap in access to health services in many
countries and called for effective strategies to improve equity [1]. Globally an estimated 1.3 bil-
lion people do not have access to effective and affordable health care, and of those who have
access about 170 million are forced to spend more than 40 percent of their household income
on medical treatment [2]. Financial barriers are a key limitation to accessing health services in
LMICs where out-of-pocket (OOP) payments finance a significant proportion of health expen-
diture. In 33 mostly low-income countries, direct OOP payments represented more than 50%
of total health expenditures in 2007 [3]. There is high probability of many households in
LMICs being pushed into poverty when faced with substantial medical expenses, particularly
when this is combined with a loss of income due to ill-health [4]. Indeed it is increasingly rec-
ognised that measures to promote financial protection through universal health coverage
(UHC) represent major components in global efforts to fight poverty and this is reflected in the
UN Sustainable Development Goals [5].
UHC stipulates that people should be able to access the health services they need without
risking financial ruin or impoverishment [6,7]. Effective implementation of this principle
requires a robust health financing system which guarantees a fair distribution of the burden of
paying for health care according to ability-to-pay (ATP) and benefits from health care spend-
ing according to need [8,9]. Health systems in many LMICs are financed through key sources
such as taxation, social health insurance contributions, private health insurance premiums, and
out-of-pocket payments [10]. Not all these financing sources promote equity and therefore
facilitate the move towards UHC. Government spending on health, although not explicitly
stated, is generally expected to benefit the poor more than the better-off [11].
Benefit incidence analysis (BIA) and financing incidence analysis (FIA—also referred to as
progressivity analysis) are the most well recognised tools for assessing the extent to which public
spending on health benefit the poor and are increasingly being used by governments and interna-
tional agencies such as theWorld Bank to assess progress toward UHC targets [12,14]. BIA esti-
mates the distributional impact of public spending on health care. It measures the extent to
which different socio-economic groups benefit from public subsidies through their use of health
services [8,13]. A key step in the computational process is to subtract any out-of-pocket payment
made in the course of using health services in order to arrive at the actual subsidy received [15]
(Box 1). FIA assesses the distribution of the burden of health financing across socio-economic
groups, and the extent to which this burden affects the underlying distribution of income [16].
To maintain an equitable health financing system, it is generally accepted that payment for
health care must to be on the basis of ATP. FIA or progressivity analysis measures the departure
from proportionality in the relationship between payments for health care and ATP [8,17]. The
progressivity of a health care financing system is computed in two phases–first, by computing the
progressivity of each source of health care finance, and second, by weighting the progressivity of
the different financing sources by their shares in total health finance often estimated from National
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Health Account data to obtain overall progressivity. A progressive financing system is one in
which households with higher income contribute a higher share of their income towards health
than do those with lower income and a regressive system is the opposite [6,10].
While several countries have reformed their health care sector over the last decades to move
towards a more pro-poor system, the evidence on progress towards equitable health financing
in LMICs overall remains sketchy. A recent systematic review by Anselmi and colleagues [18]
focuses on equity in allocation of public health sector expenditures in LMICs. It does not cover
the distribution of the burden of financing the health system across households with different
ATP–a key aspect of health financing equity. This systematic review builds on Anselmi’s work
by assessing the evidence on health financing equity in LMICs drawing specifically on studies
that use BIA and FIA as the principal methodology and were published between 1994 and
October 2013. The aim is to provide evidence on advancement in health financing equity in
LMICs to inform the debate on universal health coverage. The 20-year period chosen was to
enable the capture of more recent evidence. Insights from this review may be useful for assess-
ing the performance of health systems in LMICs and also help policymakers and planners to
further strengthen their current health financing arrangements.
Methods
Ethics
This is a systematic review and requires no ethics approval. However, the entire study under
which this review is conducted has been approved by the Human Research Ethics Committee
Box 1. Measuring benefit and financing incidence.
Approach Description
BIA Undertaking BIA involves following a number of steps: ranking the study population by a
living standard measure, assessing the rate of utilisation of different types of health
services, estimating the unit cost of each type of service, and multiplying the utilisation
rates and unit costs to determine the amount of subsidy. Direct user fees are deducted
before arriving at the final amount of government subsidy [15]. The amount of subsidy is
usually the difference between the costs incurred for providing the services and the fees
paid by the user expressed as:
Ski = Cki−Fki = cki−fkiqki = qki (cki−fki) = skiqki
where Ski are the subsidies that individual i receives from subsector k (e.g. hospital
inpatient care), Cki are the costs incurred by providers in subsector k in providing services
to individual i, Fki are the fees paid by individual i to the provider in subsector k, qki is the
number of units of service of type k consumed by individual i, and cki, fki and ski are the unit
costs, fees and subsidies, respectively, for sector k for individual i. At the individual level,
only Fki and qki are recorded in the household survey data. The goal of BIA is to estimate
the distribution of the Ski by income [13].
FIA A key indicator for measuring the progressivity of a health financing system is the Kakwani
index (KI) [63], which is defined as twice the area between the concentration curve of
health payments and the Lorenz curve [17]. The KI is calculated as:
πK = C−G
where C is the concentration index for health payments and G is the Gini coefficient of the
ATP variable. The value of πK ranges from -2 to 1. A negative value indicates a pro-rich or
regressive health care payment system. A positive value indicates a progressive financing
system with the concentration curve of health care payment lying outside the Lorenz
curve. Where health care payment is proportional to ATP, the concentration curve lies on
top of the Lorenz curve and the index is zero [12].
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of UNSW Australia (Approval number: HC13269); the Fiji National Health Research Commit-
tee (Approval # 201371); and the Timor-Leste Ministry of Health (Ref MS/UNSW/VI/218).
Search strategy
We searched the published and unpublished literature including the following bibliographic
databases: Medline, Embase, Scopus (Health Sciences and Social Sciences and Humanities),
Global Health and CinAHL. We also searched key Economics databases including EconLit and
Business Source Premier. Bibliographies of identified articles and reports on BIA and FIA were
examined to obtain additional documents. Finally, key individuals with expertise in BIA and
FIA were contacted for personal recommendations. For the grey literature we searched the
websites for relevant organisations supporting health care in LMICs including World Bank,
United Kingdom Department for International Development (DFID), Asian Development
Bank (ADB), World Health Organization (WHO), United States Agency for International
Development (USAID) and the Organisation for Economic Co-operation and Development
(OECD).
A range of key terms related to equity in health financing generally, and more specifically,
benefit and financing incidence analyses, were used for the electronic database searches. They
included: (equity OR inequity OR equitable OR inequitable OR pro-poor OR pro-rich OR
progressiv OR regressiv OR proportio) AND (public OR government OR state) AND
(health OR health care OR health system financ OR paymen OR expenditur OR spending
OR subsid OR subsidized) AND (benefit incidence OR benefit incidence analysis OR bia OR
financing incidence OR financing incidence analysis) AND (low and middle income OR lmic
OR developing OR least developed countr). Different combination of these search terms were
applied to the various databases and the search was limited to 1994 and October 2013 and also
to low- and middle income- countries. Low-income countries, according to the World Bank,
are those with a GNI per capita of $1,045 or less in 2013, while middle-income countries are
those with a gross national income (GNI) per capita of more than $1,045 but less than $12,746
[19]. All the countries included were classified as low and middle income at the time the review
was undertaken. The electronic search was undertaken independently by two researchers (AA
and JP).
Screening and selection of studies
The selection of studies to be included in this review was done in three stages based on pre-
developed selection criteria (Table 1). At stage 1, we checked all the search results (n = 512) to
remove duplicates, non-English references, and references that were outside the stipulated time
frame. Three potentially useful non-English references were excluded. The screening was done
independently by two reviewers (AA and JP). The stage 2 screening involved the two indepen-
dent reviewers reading titles and abstracts of all references that passed the stage 1 screening
(n = 305) to assess their relevance to the topic. In the final stage, the full texts of the references
that passed the stage 2 screening (n = 87) were assessed against the selection criteria for the
final selection of studies to be included in the review (n = 24). Differences in opinion at any
stage of the screening process were discussed and resolved before moving to the next stage. Sin-
gle papers that apply both BIA and FIA in one country were treated as one study with the
results reported under the appropriate headings. However, the results of papers that focus on
multiple countries were disaggregated by country and then by method of analysis (BIA or
FIA). For the FIA, we excluded studies that focus on only one health financing mechanism
such as OOP spending or social health insurance because determining the progressivity of a
health financing system requires an assessment of all financing sources in the country [6,20].
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We built an Endnote library for all potentially relevant studies that passed the stage 1
screening.
Data extraction
Two researchers (AA and JP) critically reviewed all the papers included in the study for evi-
dence on equity in health financing. Each paper was reviewed independently and information
was extracted into a database using a pre-established standard data entry format. We followed
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist
in gathering the relevant information (S1 PRISMA Checklist). Basic information describing
each of the studies such as names of authors, title, year of publication, country of focus, method
and data sources, key findings, and main conclusions were extracted. Any differences between
the two reviewers in terms of data extracted were resolved by consensus among all authors.
Overall, less than 5% of data extracted were discrepant and were resolved by consensus.
Appraisal of the quality of each study during the review and data extraction phase was carried
out paying particular attention to methodological soundness, the appropriateness of the study
design and the overall weight of evidence on health financing equity.
The data extracted were largely qualitative although the concentration and Kakwani indices
were reported for the majority of the BIA and FIA studies. The BIA studies typically reported
on whether the distribution of public subsidy across different socioeconomic groups was pro-
poor or pro-rich at various levels of a health system (e.g. primary, secondary and/or tertiary),
service types (e.g. outpatient/inpatient) and/or sector (public/private) depending on data avail-
ability. The FIA studies reported on whether, and the degree to which, payment for health care
has been progressive, regressive or proportional across households as ranked by their ATP.
Each member of the review team critically examined the evidence extracted into the database
table to ensure it addressed the objective of the review.
We assessed the risk of bias in each study at both the study and outcome levels. For all the
studies we critically reviewed the methodology, including whether approaches followed were
sufficiently described, sources of data adequately reported, and findings appropriately pre-
sented. We have published a protocol that outlines the key steps for conducting BIA and FIA
and the type of data required: http://bmjopen.bmj.com/content/4/12/e006806.full. We assessed
the extent to which each study followed established methodologies for computing the benefits
or burden from health care. For the BIA studies, the assessment of risk of bias included whether
Table 1. Inclusion and exclusion criteria.
Criteria Inclusion Exclusion
Time period From January 1994 to October
2013
Before 1994
Language English Non-English
Origin of study Sub-Saharan Africa, Asia-Pacific,
Latin America, Middle East
Developed countries
Methodology BIA & FIA (including progressivity
analysis)
Health financing but not using BIA or FIA
Dimension of
study
Single & multi-country Studies focusing on concept or methodology
FIA studies reporting on all
financing mechanisms
Studies focusing on only one financing source (e.g.,
out-of-pocket) or only one service (e.g. anti-retroviral
therapy or ART financing)
Studies focusing exclusively on
health sector
Studies comparing health with other sectors
doi:10.1371/journal.pone.0152866.t002
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nationally representative household datasets were used or whether primary data was collected;
and if so, whether there was any sampling bias. We further assessed the extent to which the uti-
lisation data allowed for reasonable calculation of rate of health service use and how unit cost
was calculated. For the FIA studies, we followed the recommended methodological approach
in key studies including O’Donnell et al. [12]; Mills et al. [6]; Akazili et al. [21] and Limwatta-
nanon et al. [9] by assessing whether the progressivity of each health financing source was first
computed before aggregating to obtain the progressivity of the overall health financing system.
We also assessed whether the FIA studies reported concentration and Kakwani indices, and
whether sensitivity analysis was performed. Studies that had gaps based on their assessment,
were considered to have weak evidence on health financing equity.
Analysis of data
The BIA studies included in this review (n = 18) differ in terms of the way results are presented.
We classified the studies into three groups: those presenting concentration indices (CIs) to
illustrate the extent of equity in the distribution of health care benefits (n = 12); those present-
ing percentage shares of subsidy received by population quintiles or deciles (n = 5); and those
using only concentration curve (CC) to depict equity in the distribution of benefits (n = 1).
Some of the studies combined different approaches, especially percentage share of subsidy and
concentration index.
To analyse the data extracted from the BIA studies in a uniform manner, we developed a
scale (from -3 to 3) to score each study based on the degree of equity in distribution of benefits
reported. For those studies presenting CIs illustrating pro-poor distributions, we assigned a
value of 1 where CI< 0.1; 2 where CI =>0.1< = 0.2; and 3 where CI> 0.2. The choice of mid-
points was informed by the range of concentration indices reported across the studies. Negative
values were assigned where the distribution is pro-rich and a score of zero is assigned where it
is proportional. It must be noted that the values assigned to score the studies are independent
of whether the reported concentration index is negative or positive. For studies presenting per-
centage share of subsidy by quintiles or deciles and without CIs, we applied the same scale but
using different thresholds: 1 where the poorest quintile/decile received less than 5% share of
subsidy over and above its population share; 2 where 5–10% is received; and 3 where more
than 10% is received. We assigned negative values using the same scale where the distribution
is pro-rich and a zero where it is proportional. Finally, for those studies using concentration
curves to illustrate the extent of equity, we applied the same scale (-3 to 3) but the thresholds
were based on observation of the CC and its proximity to the 45 degree equality line (see Box 2
for summary of approach).
The FIA studies were more uniform in their approach to presenting findings: combining
concentration with Kakwani indices to measure the degree of progressivity. We analysed the
FIA data by comparing the Kakwani indices for the different sources of financing and their cor-
responding total indices. Because of the qualitative nature of the data from the BIA and FIA
studies coupled with differences in the study settings, meta-analysis could not be undertaken;
instead, a narrative synthesis approach [22] was employed in the analysis and presentation of
the overall evidence. The lead reviewer (AA) drafted the overall report which was checked and
commented on independently by all authors.
Results
Selection process and outcome
A total of 512 references were retrieved from the electronic databases and websites of develop-
ment agencies. The full texts of 87 references were assessed against the selection criteria and 24
Equity in Healthcare Financing in Low- and Middle-Income Countries
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studies were judged appropriate for inclusion. Of the 24 studies, 11 reported exclusively on
BIA, six on FIA and seven on both BIA and FIA (Fig 1).
Study characteristics
A total of 18 BIA studies compared to 13 FIA were obtained from the 24 papers after separating
those papers that combined the two methodologies (Table 2). Fifty percent (n = 12) of the
papers included in the review originated from sub-Saharan Africa, 38% (n = 9) from the Asia-
Pacific region and 12% (n = 3) from Latin America and Middle East combined. About 71%
(n = 17) of the papers were published between January 2011 and October 2013, indicating
recent growth in the popularity of BIA and FIA for measuring health care financing equity in
LMICs. In terms of country of focus, although more studies originated from sub-Saharan
Africa than from the Asia-Pacific region, there were more countries covered in Asia-Pacific
(13) than in sub-Saharan Africa (10) and this is primarily because of two large multi-country
studies undertaken in Asia-Pacific in 2007 and 2008 [11,12]. Some countries in these regions
including Kenya, Ghana, and Thailand had multiple BIA and/or FIA studies. The World Bank
published seven of the 24 papers–four in sub-Saharan Africa and three in Asia-Pacific. The
papers originating from China, India and Nigeria were partial analysis focusing on selected
provinces or states rather than the entire country [11,12,23,24,25]. All the studies used either
existing secondary datasets from nationally or regionally representative surveys or a combina-
tion of secondary and primary data. Four papers from sub-Saharan Africa gathered primary
data to complement the existing secondary household survey and other datasets [6,21,26,27].
These four papers also focused on both the public and private sectors. From a methodological
or reporting perspective, no risk of bias was identified within or across the studies included in
this review as they all followed standard approaches for undertaking and reporting BIA and
FIA results. However, potential risk of sampling bias could not be ruled out for the BIA studies
which gathered primary data from sampled districts.
Box 2. Summary of approach to scoring the BIA studies.
a) Studies reporting concentration index where
CI <0.1 assign 1 if pro-poor or -1 if pro-rich
CI = > 0.1 < = 0.2 assign 2 if pro-poor or -2 if pro-rich
CI > 0.2 assign 3 if pro-poor -3 if pro-rich
b) Studies reporting % shares of subsidy
by population quintile or decile
where
share of poorest or richest group is <5% above
population share assign 1 if pro-poor or -1 if pro-rich
share of poorest or richest group is = >5% < = 10%
above the population share assign 2 if pro-poor or -2 if
pro-rich.
share of the poorest or richest group is > 10% above
population share assign 3 if pro-poor or -3 if pro-rich
c) Studies using concentration curve to
depict equity of distribution
Assign score -3 to 3 depending on the proximity of the
concentration curve to the 45 degree line of equality.
Equity in Healthcare Financing in Low- and Middle-Income Countries
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Distribution of health financing benefits and burden
Sub-Saharan Africa. Evidence from the BIA studies demonstrates consistently pro-rich
distributions of total health financing benefits in sub-Saharan Africa. The better-off in most of
the countries benefited more from health care spending through their use of health services
than the poor (Fig 2). About 78% (n = 14) of all the BIA studies from sub-Saharan Africa
reported a pro-rich distribution of health care benefits (Fig 2). At the hospital outpatient level,
the pro-rich distribution was particularly strong with 12 out of 14 studies (86%) reporting this
finding compared to 7 out of 15 (47%) at the primary health care (PHC) level. Ten of the BIA
studies from sub-Saharan Africa reported the distribution of inpatient care and 80% found it
pro-rich. About 40% (n = 6) of the studies from sub-Saharan Africa reported pro-poor distri-
bution of health care benefits at the PHC level (Fig 2).
In terms of individual countries, only the BIA study from Nigeria [25] focusing on a limited
set of priority public health services found the total distribution of benefits to be pro-poor with
a concentration index of -0.11. However, this finding was not surprising as the study focused
on a set of priority health services freely provided at PHC levels and no hospital level distribu-
tion was reported (Fig 2). For the majority of the countries in sub-Saharan Africa, the distribu-
tion of total benefits was pro-rich despite the distribution of PHC services favouring the poor
in some countries. In Ghana for example, the World Bank [28] found that the distribution of
Fig 1. PRISMA Flow Diagram for Selection of Studies.
doi:10.1371/journal.pone.0152866.g001
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PHC benefits to be pro-poor but the total distribution, under different unit cost assumptions,
was pro-rich largely as a result of hospital level care that benefited the better-off. Chuma et al.
[26] obtained similar results in Kenya in 2003 where services in public PHC facilities had a
pro-poor distribution but a pro-rich distribution in public and private hospitals influenced the
Table 2. Characteristics of studies included in the review.
Author Year Country Methodology Data
sources
Level of
analysis
Sector
BIA FIA Primary Secondary National Sub-
national
Public Private
Sub-Saharan
Africa
Onwejekwe et al 2012 Nigeria X X X X
Chuma et al. 2011 Kenya X X X X X X
Munge and
Briggs
2013 Kenya X X X X
Mills et al. 2012 Ghana, Tanzania & South Africa X X X X X X X
Akazili et al. 2012 Ghana X X X X X X X
Mangham 2006 Malawi X X X X
Mtei et al. 2012 Tanzania X X X X X X X
Castro-Leah
et al.
2000 Cote d’Ivoire, Ghana, Guinea,
Kenya, Madagascar, South
Africa and Tanzania
X X X X
World Bank 2012 Ghana X X X X X
World Bank 2012 Kenya X X X X
World Bank[59] 2012 Malawi X X X X
World Bank 2012 Zambia X X X X
Asia-Pacific
Limwattananon
et al.
2011 Thailand X X X X X
Yu et al. 2008 Malaysia X X X X
Chen et al. 2012 China (Gansu Province) X X X X
Chakraborty
et al.
2012 India X X X X
World Bank[60] 2012 Mongolia X X X X X
World Bank [61] 2012 Pakistan X X X X
World Bank [62] 2012 Vietnam X X X X X
O’Donnell et al. 2007 Japan*, Hong Kong*, Korea*,
Taiwan*, Indonesia, China,
Thailand, Bangladesh, Sri Lanka,
Punjab (India) Kyrgyz, Nepal,
Philippines.
X X X X X
O'Donnell et al. 2008 Japan*, Hong Kong*, Korea*,
Taiwan*, Indonesia, China,
Thailand, Bangladesh, Sri Lanka,
Punjab (India) Kyrgyz, Nepal,
Philippines.
X X X X X
Other LMICs
Uga and Santos 2007 Brazil X X X X
Angeles et al. 2007 Ecuador X X X X
Halasa &
Nassar
2010 Jordan X X X X
* Not included in the analysis as they are not classified as low and middle income.
doi:10.1371/journal.pone.0152866.t004
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overall distribution to become pro-rich. In Malawi and South Africa the total distribution of
benefits was close to proportional as evident in the BIA studies by Mangham [29], Mills et al.
[6] and Castro-Leal et al [30].
Several of the BIA studies from sub-Saharan Africa covered both the public and private sec-
tors in a system-wide analysis. The study by Chuma et al. in Kenya [28], Mills et al. in Ghana,
Tanzania and South Africa [6]; Akazili et al. in Ghana [21] and Mtei et al. in Tanzania [27] all
adopted a system-wide approach looking at both the public and the private sector. Apart from
Chuma et al. the rest of these studies were part of a larger consortium to develop strategies for
health insurance and equity in less developed countries (SHIELD) [21] and hence, the method-
ologies were similar. The World Bank study in Ghana [28] also covered the private sector.
The distribution of health financing burden in sub-Saharan Africa, based on the FIA studies
evaluated, was generally progressive (Fig 3). Thus, households with higher income contributed
a higher share of their income towards health care than those with lower income. About 75%
(n = 6) of all the FIA studies from sub-Saharan Africa reported a progressive distribution of
total health financing. The four main sources of health financing that emerged from the analy-
sis are taxation (direct and indirect), out-of-pocket, mandatory health insurance (social health
insurance), and voluntary or private health insurance. Two of these financing sources, taxation
and mandatory health insurance were found by the vast majority of the FIA studies (100% for
taxation and 86% for mandatory insurance) to have a progressive distribution. Indirect taxes,
particularly Value Added Tax (VAT), were regressive in the majority of the FIA studies but the
degree of regressivity was often not enough to overturn the highly progressive direct taxes.
Out-of-pocket payments and voluntary/private health insurance were found to be regressive.
OOP payment was regressive in all the countries except in Zambia where the World Bank [31]
found the distribution to be proportional (7 out of 8 FIA studies from sub-Saharan Africa
reported the regressivity of OOP payment). Voluntary or private health insurance was moder-
ately regressive compared to OOP payment (50% of FIA studies found this financing source
regressive).
Fig 2. Equity scores from the BIA studies depicting the distribution of health care benefits.
doi:10.1371/journal.pone.0152866.g002
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Based on the FIA studies from sub-Saharan Africa, Kenya was the only country where the
overall distributions of the health financing burden were found to be in favour of the better-off
(Fig 4). In summary, the results from the BIA and FIA studies evaluated for sub-Saharan Africa
were highly consistent in pointing to a pro-rich distribution of health care benefits and a gener-
ally progressive health financing system but with significantly regressive OOP payment and
mildly regressive voluntary/private insurance mechanisms.
Asia-Pacific. The results of studies originating from Asia-Pacific differ to some extent
from those coming from sub-Saharan Africa although there were some similarities especially
in regards to the BIA. About 64% (9 out of 14) of the BIA studies reported a pro-poor distribu-
tion of health care benefits at the PHC level compared to the 40% for sub-Saharan Africa (Fig
2). At the hospital outpatient level, the distribution of benefits was pro-rich similar to sub-
Saharan Africa with 80% (n = 12) of studies reporting such finding, close to the 86% of studies
found in sub-Saharan Africa. The distribution of inpatient care in Asia-Pacific was slightly less
pro-rich than hospital outpatient care, with 73% of studies compared to 80% reporting these
findings. The overall distribution of health care benefits in Asia-Pacific was pro-rich (67%)
although to a lesser extent compared to sub-Saharan Africa (72%).
In terms of individual countries in Asia-Pacific, the majority of the BIA studies (60%)
including those from India, Indonesia and Vietnam reported a pro-poor distribution of bene-
fits at the PHC level and a pro-rich distribution at the hospital level (Fig 2). However, the BIA
studies from China, Pakistan, Bangladesh and Nepal found a pro-rich distribution of benefits
at both the PHC and hospital levels, making the distribution of total health financing benefits
in these countries firmly pro-rich (Fig 2). The final set of BIA studies from Thailand, Malaysia,
Sri Lanka and Mongolia found a pro-poor distribution of benefits at both the PHC and hospital
levels although inpatient care in Sri Lanka and hospital outpatient in Mongolia were marginally
pro-rich. These four countries appear to be making significant strides towards health financing
equity. Thailand and Malaysia, in particular, seem to have established a strongly pro-poor dis-
tribution of health care benefits at all levels of the health system [9,11]. In terms of covering the
private sector, only one of the BIA studies from Thailand [9] incorporated some analysis of the
use of private health facilities.
Fig 3. Kakwani indices for the four main financing sources reported by FIA studies from sub-Saharan Africa and Asia-Pacific.
doi:10.1371/journal.pone.0152866.g003
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Fig 4. Kakwani index of total distribution of health care payments reported by FIA studies from sub-Saharan Africa and Asia-Pacific.
doi:10.1371/journal.pone.0152866.g004
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The distribution of health financing burden in Asia-Pacific appears much more equitable
than in sub-Saharan Africa; nearly 93% (n = 13) of all FIA studies from Asia-Pacific reported a
progressive distribution of total health financing burden (Fig 3). Taxation and mandatory
health insurance (social health insurance) were the most progressive financing sources with
93% and 90% respectively of the FIA studies reporting this finding. Voluntary health insurance
was the least progressive with 57% (n = 4) of the studies observing this pattern of distribution.
Studies from eight countries (Malaysia, Mongolia, Bangladesh, Vietnam, Indonesia, Sri-Lanka,
Nepal and Philippines) reported a progressive distribution of financing burden across all
financing in those countries. In several of the countries, however, although the overall distribu-
tions were progressive, some of the financing sources had a regressive distribution. An example
is Thailand where Limwattananon et al. [9] reported regressive OOP payments and private
health insurance, but the overall distribution was progressive and this was driven by a highly
progressive tax distribution. There were similar findings from India, Kyrgyz Republic and
China where at least one financing source was found to be regressive or proportional. Regard-
ing the total distribution, China was the only country where the overall distribution of health
financing burden was found to be regressive [23] (Fig 3).
One major difference between the FIA results from Asia-Pacific and sub-Saharan Africa is
that the burden of OOP payment in Asia-Pacific was borne largely by the better-off while in
sub-Saharan Africa the poor suffer disproportionately from direct payment. In addition to this,
the better-off in Asia-Pacific also bear the largest share of the burden of paying for mandatory
health insurance (largely social health insurance—SHI); all but one study reported a progres-
sive SHI distribution. A similar result of a progressive SHI was obtained in sub-Saharan Africa.
This may be due to the fact that in most countries SHI is linked to formal sector employment
and as a result the burden of payment for this insurance rests largely on formal sector employ-
ees who may be relatively better-off. The distribution of voluntary/private health insurance
burden in Asia-Pacific was found to be progressive albeit less so than other financing sources
(Fig 2). Nonetheless, voluntary/private health insurance in Asia-Pacific appears more equitable
than in sub-Saharan Africa, where it was found to be mildly regressive.
Other LMICs. Only three BIA and FIA studies included in this review originated outside
sub-Saharan Africa and Asia-Pacific. Two of these studies are from Latin America (Brazil and
Ecuador) and consist of one BIA and one FIA. The Brazilian study [32] reported on the pro-
gressivity of the health financing system and found the overall distribution to be regressive
despite a progressive distribution of mandatory health insurance and voluntary/private health
insurance. The regressive distribution appears to be driven largely by highly regressive OOP
payments–which are similar to the picture from sub-Saharan Africa. The BIA study from Ecua-
dor [33] found the distribution of health care benefits at the PHC level to be pro-poor but inpa-
tient care was pro-rich making the total distribution proportional (Fig 2). The only study from
the Middle-East [34] reported on the distribution of basic health care (at the PHC level) and
found a strongly pro-poor pattern with the poorest group receiving 33.8% of the total benefit
(equity score of 3) compared to the richest group receiving just 4% (Fig 2).
Discussion
This systematic review assessed the evidence on health financing equity in LMICs to inform
the debate about universal health coverage. The review draws exclusively on studies that use
benefit and financing incidence analyses as analytical methods to evaluate health financing
equity. Our findings, although have been presented separately, should be seen as complemen-
tary in terms of understanding the overall progress towards health financing equity. The results
of this review can be summarised as follows: 1) the distribution of total health financing
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benefits in sub-Saharan Africa and Asia-Pacific is pro-rich but more so in sub-Saharan Africa
than in Asia-Pacific, and this is driven by a highly pro-rich distribution of hospital services; 2)
the distribution of health financing benefits at the PHC level is significantly pro-poor in Asia-
Pacific but marginally so in sub-Saharan Africa; 3) the distribution of the burden of paying for
health care is largely progressive in sub-Saharan Africa and Asia-Pacific with the better-off
contributing a higher share of their income towards health, but variations exist in the degree of
progressivity with different financing sources. Each of these findings is discussed below. The
discussion focuses largely on the finding from sub-Saharan Africa and Asia-Pacific, as only
three studies originated from LMICs in other regions.
The pro-rich distribution of health benefits in sub-Saharan Africa and much of Asia-Pacific
warrants further attention by policy makers and researchers. This finding is not wholly surpris-
ing as it is a common feature of health systems in LMICs that the poor and rural populations
experience barriers to hospital treatment [35]. It indicates that the wave of health financing
reforms in these countries to promote universal coverage has some way to go to achieve their
goals [36,37]. Although in principle many LMIC governments have prioritised primary health
care, in practice they have not been able to shift resources in favour of the primary sector [35].
Large shares of government health spending in LMICs are still concentrated on inpatient hos-
pital services, particularly tertiary and specialised care, most of which are urban-based and
often too costly to be accessed by the poor [38]. It is crucial that timely access to secondary and
tertiary services is given to all those in need of care particularly the poor.
The marginally pro-poor distribution of health benefits at the PHC level in sub-Saharan
Africa, and to some extent Asia-Pacific, suggests that utilisation of PHC services by the poor,
especially in sub-Saharan Africa, has not seen much improvement despite the centrality of
PHC in the expansion of health services in LMICs [39]. Although traditionally health service
utilisation has been lowest among the least well off [40], there has been a perception that
poorer households may be using PHC services more because of their relative availability in
rural areas compared to hospital services. The limited evidence of pro-poor distribution at the
PHC level in this review suggests that the decade-long health reform to strengthen PHC has
had only minimal impact on service utilisation by the poor. This is partly because PHC is often
not well matched to the needs to the poor and therefore they may instead access private ser-
vices, go directly to hospital or not seek any care at all. PHC needs to be better designed to
meet the needs of the poor.
It is well recognised that affordable, effective and equitable health care requires a well-sup-
ported and comprehensive primary health care system [41]. To some extent, government
investment in PHC in sub-Saharan Africa and many LMICs still lags behind that of hospital-
based care [30]. There is the need to reallocate government resources towards PHC not only to
enhance equity but also to improve efficiency of health systems in LMICs. Traditionally the
poor tend to be the least healthy and probably have the most to benefit from health care. There-
fore the greatest health gains could be realised by concentrating marginal resources on treat-
ment of the poor [40]. Efforts to make health systems more pro-poor also need to recognise the
fact that many poor people do not use health services at all, not even primary services, for a
variety of reasons including quality [30]. Making health services available without addressing
the factors that undermine effective use of those services will not deliver sufficient benefits to
the poor.
The equity of a health financing system does not only depend on how pro-poor the distribu-
tion of its benefits is but also how the financing burden is shared. With about 93% of FIA stud-
ies from Asia-Pacific indicating that the distribution of total health financing burden is
progressive, the region appears to have taken great strides towards equity in payment for health
care. However, this progressive distribution, especially for OOP payment, seems inconsistent
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with existing knowledge that poorer households in Asia-Pacific suffer disproportionately from
direct payment for health care. Out-of-pocket payment constitutes a significant portion of
health financing in Asia-Pacific. In 2008, the proportion of OOP as a share of total health
expenditure was greater than 50% in Bangladesh, Cambodia, India, Lao People’s Democratic
Republic, Myanmar, the Philippines and Vietnam [42]. There are potential efficiency gains to
be derived from the implementation of an OOP policy in LMICs [43]. Besides generating reve-
nue to supplement the often meagre government health budget, OOP payments can enhance
access to health care for the poor, especially if richer population groups pay and the revenue
generated is invested in expanding access to services. It can also improve health systems’ effi-
ciency by encouraging rational use of services and reducing inappropriate referrals’ [43]. How-
ever, as studies have demonstrated, OOP payments have a negative impact on households,
especially poorer ones [44,45]. It has been observed that millions of people in Asia-Pacific, par-
ticularly the poor, are unable to use the health services they need partly as a result of OOP pay-
ment [42,44]. This suggests that although the rich may be bearing the largest burden of OOP
payment in those Asian countries included in this review, the poor continue to suffer from the
effects of this payment no matter how small their contributions.
The impact of OOP payment on poorer households in Africa is well documented [46,47,48]
and is supported by the findings of this review which indicated that OOP payment across the
continent is regressive (88% of the FIA studies found OOP payment to be regressive). Informal
insurance mechanisms that households use to cope with OOP payments such as charity and
use of informal credit networks are available across Africa [49]. While these mechanisms are
important in abating some of the burden associated with health care costs, they do not address
the source of such costs. Furthermore the policy implications of these informal coping mecha-
nisms are unclear since they vary from one setting to another. Within the past couple of
decades health reform in several African countries including Uganda and Ghana have led to
the removal of user fees and a move to establish formal mechanisms such as social and volun-
tary health insurance schemes [46,50]. However, some of the voluntary health insurance
schemes established in place of OOP payment have been found to be themselves regressive. In
this review approximately 50% of the FIA studies from sub-Saharan Africa found the distribu-
tion of voluntary/private health insurance to be regressive. Some have attributed this partly to
design issues, including the flat rate of premium charged to all subscribers regardless of their
socioeconomic status [6]. What remains unclear however is how a voluntary payment scheme
can be regressive. A recent willingness to pay study in Malaysia found a higher preference for
voluntary community-based health insurance (VCHI) compared to OOP payment and sug-
gested that risk aversion on the part of households may have played a role [51]. From this, one
can speculate that many households in sub-Saharan Africa prefer the less regressive option of
voluntary health insurance to the more regressive and riskier alternative of OOP payments.
Looking broadly at the results one may wonder whether the changes in health financing
equity, as observed in this review, reflects progress made in UHC in the countries covered by
the review. Available evidence suggests that, at least, in some countries the improvements in
health financing equity may have contributed significantly to developments in UHC. However,
in others such evidence appears inconclusive. In Thailand, for example, there is a strong indica-
tion that achievements in UHC are underpinned by a concerted national effort to strengthen
the health financing system to make it more pro-poor and this has led to positive UHC out-
comes including equitable access to health services, low level of unmet health needs, and high
level of financial risk protection [52]. Annual per capita outpatient visits and inpatient admis-
sions increased from 2.41 and 0.067, respectively, in 2003 to 3.64 and 0.119 in 2011. OP visits
among the poorest quintile were disproportionately higher than for the richest quintile. Simi-
larly, IP admissions were concentrated more among the poorest quintile of the population than
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the wealthiest quintile [52]. In terms of financial risk protection, as a result of the health financ-
ing reforms, direct health payments by households fell from 45% of total health spending in
1994 to 15% in 2010 leading to a marked drop in the number of households impoverished by
health payment [52]. These achievements coincide with the progress in health financing equity
as demonstrated by the BIA and FIA studies in this review.
In the case of sub-Saharan Africa where the majority of the BIA studies show a pro-rich dis-
tribution of health benefits, there appears to have been only marginal progress towards UHC.
For example, in Kenya, there have been some improvements in access to antenatal care (ANC)
in the last decade with deliveries occurring in health facilities increasing from 40% in 2003 to
61% in 2014. However, births by women in the lowest wealth quintile was 16% and 30% in
2003 and 2014 respectively, compared to 74% and 93% by those in the highest quintile for the
same period [53,54]. A similar situation can be found in Ghana where deliveries assisted by
skilled professionals have increased from 47% in 2003 to 74% in 2014 but assisted deliveries by
women from the lowest socioeconomic quintile remained significantly lower (47%) than those
for the wealthiest quintile (97%) [55,56]. These, to some extent, confirm the pro-rich distribu-
tion of health care benefits as depicted by the BIA studies from the region.
The regressive nature OOP payments in sub-Saharan Africa as evident in the FIA studies
also seems to have some practical implications for health seeking behaviour and UHC in the
region. Evidence from recent Demographic and Health Surveys (DHS) in many countries dem-
onstrates that most women between the ages of 15–49 face significant financial barriers to
accessing health care. In Nigeria, 42% of women cited ‘money’ as a key barrier when it comes
to accessing health care. Nearly 53% of women from the lowest wealth quintile compared to
25% of those from the richest quintile made such observation [57]. A similar percentage of
women in Ghana (41.7%–59% from the lowest wealth quintile compared to 23% from the rich-
est quintile) and Kenya (36.7%–58% from the lowest wealth quintile compared to 17% from
the richest quintile) mentioned ‘money’ as a barrier to accessing health care [54,56]. While
there was inadequate data to assess trends over time, these insights corroborate evidence from
the FIA studies suggesting that direct payments for health care is more a problem for the poor
than the rich.
Limitations
There were some gaps and inconsistencies in the data presented across the different studies
that limited our review. First, in some of the BIA studies the utilisation data used were not dis-
aggregated by type of service (e.g. outpatient–inpatient) and/or by type of facility (hospital, and
non-hospital; health centres, clinics, etc.). Without such disaggregation, it is difficult to fully
assess the nature of distribution of health care benefits. Second, only a handful of the BIA stud-
ies attempted to assess utilisation of private sector health facilities. BIA is typically concerned
with the distribution of government resources and hence the assessment of the private sector
may seem inconsistent with the dictates of the approach. However, in many LMICs a signifi-
cant proportion of public funds support private health providers, especially faith-based organi-
sations. For example, the Christian Health Association of Ghana (CHAG) provides an
estimated 42% of total health services in the country and about 41% of its operating budget
comes from the government of Ghana [58]. Any assessment of health financing equity in
LMICs will not be complete without accounting for the utilisation of private sector facilities.
Third, there was no consistency in the way the need for health care was handled across the
BIA studies. BIA per se does not indicate how much health care a person needs; it only mea-
sures how the benefits from public spending on health are distributed across households
ranked into socioeconomic groups. It is assumed that people from lower socioeconomic
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backgrounds generally have higher need for health care than those from wealthier back-
grounds. But how much higher, and is the distribution of these benefits in accordance with health
care needs? To address this issue BIA often assesses relative need for health care across house-
holds and compares this with the amount of subsidy received. Varied indicators of need are
used, usually depending on what datasets are available. For example, many BIA studies in high
income countries use self-assessed health status to estimate the need for health care across
households. Likewise, several national surveys in LMICs include questions on self-reported ill-
ness which are commonly used to proxy health care need in BIA. There is no consistency in
adjusting for or assessing health care need and this may explain some of the difference in bene-
fit incidence across countries.
In addition to these limitations, our method of analysing the data also had some limitations.
Several of the BIA studies assessed equity in distribution of health care benefits over time (differ-
ent years). Although all results were reviewed, we focused largely on the most recent year, which
prevented a detailed analysis of changing patterns of health financing equity within countries.
However, this review was more interested in equity across LMICs than within countries, and
besides, only a few studies undertook such multi-year analysis. The BIA studies conducted by the
World Bank evaluated inequality in the incidence of government health spending under three
different unit-cost assumptions. In this review we concentrated on the results under the constant
unit-cost assumption. Consideration of the other assumptions may have altered the degree of
equity in the distribution of benefits reported by thoseWorld Bank studies.
Finally, BIA and FIA, as important as they are, are only two of a number of different mea-
sures available for assessing the fairness of health care financing. Other measures of equity
such as catastrophic health expenditures, which assess the degree of impoverishment of house-
holds resulting from health care payments, can be used to measure health financing equity.
However, such measures commonly focus on single health financing mechanisms such as OOP
spending or social health insurance and do not provide a complete picture of the entire health
financing system. As indicated in the methods section, such studies using single measures of
equity were excluded from this review because the focus here is on equity of the overall health
financing system.
Conclusions
Equity in health financing in LMICs with regard to the distribution of health care benefits has
seen little improvement despite the high priority given to it in recent global initiatives to pro-
mote UHC such as the sustainable development goals (SDGs). This systematic review has
shown that the distribution of total health care benefits (measured in terms of health service
utilisation) benefit the better off more than the poor. Even primary health care services, which
are often presumed to be pro-poor, were only marginally so in sub-Saharan Africa. Some coun-
tries in Asia-Pacific, namely Thailand, Malaysia and Sri-Lanka, appear to have made significant
progress towards distributing health financing in favour of the poor. In terms of the distribu-
tion of health financing burden, the vast majority of the studies reviewed found a progressive
distribution across all financing sources in Asia-Pacific, but in sub-Saharan Africa, out-of-
pocket and voluntary/private health insurance payments were regressive. Overall, policy mak-
ers in LMICs, especially those in sub-Saharan Africa, need to increase their efforts to shift gov-
ernment resources towards the poor if the goal of universal health coverage is to be realised.
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